The US Food and Drug Administration has approved as a 510(k) PerkinElmer’s NeoGram Amino Acids and Acylcarnitines Tandem Mass Spectrometry Kit, which will be used to screen newborns for certain metabolic disorders. The test can screen “more than 40” disease markers with one sample, PerkinElmer said.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.